Status:

UNKNOWN

Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial

Lead Sponsor:

VENTO GIOVANNI

Conditions:

Bronchopulmonary Dysplasia

Chronic Pulmonary Insufficiency of Prematurity

Eligibility:

All Genders

7-10 years

Phase:

PHASE2

Brief Summary

This is an unblinded monocentric pilot superiority trial that will be conducted in a IIIlevel NICU at Fondazione Policlinico Agostino Gemelli - IRCCS. The aim of the study is to test the hypothesis th...

Detailed Description

Rationale and plausibility of the study. Despite the recent advances in perinatal care, bronchopulmonary dysplasia (BPD) still represents one of the most devastating conditions in premature infants wi...

Eligibility Criteria

Inclusion

  • 1\. Extremely low gestational age newborn infants (GA \< 28 weeks) - gestational age matching between maternal dates and/or early antenatal ultrasound
  • 2\. Singleton or multiple birth
  • 3\. Postnatal age between 7 and 10 days
  • 4\. Invasive mechanical ventilation still needed
  • 5\. Fraction of inspired oxygen (FiO2) of more than 0.30 and/or an oxygenation index of 8 or more for at least 6 hours
  • 6\. Stable cardiovascular condition
  • 7\. Informed consent form signed by parents or legal guardian

Exclusion

  • 1\. Major congenital malformation (i.e., infants with genetic, metabolic or endocrine disorder diagnosed before enrolment)
  • 2\. High index of suspicion of infection before enrolment
  • 3\. Neurological conditions that might contraindicate extubation
  • 4\. Inotropic agents needed
  • 5\. Pneumothorax
  • 6\. Hemodynamically significant ductus arteriosus
  • 7\. Surgical intervention within the past 72 hours
  • 8\. Partecipation in another interventional clinical study that may interfere with the results of this trial
  • 9\. Known hypersensitivity to the drug or to one of the excipients

Key Trial Info

Start Date :

December 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04825197

Start Date

December 1 2021

End Date

February 1 2025

Last Update

December 7 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fondazione Policlinico Agostino Gemelli IRCCS

Roma, Italy, 00168